Here, we aimed to further characterize the JAK/STAT pathway in PTCL by investigating whether the activation of the pathway quantified with immunohistochemistry correlates with the frequency of JAK, STAT, and RHOA mutations. Here, RHOA is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.